Immunotherapy treatment for cancer offers the potential for many different types of combinations since these treatments are less toxic then chemotherapy and radiation
Phase 1 clinical trial to start which combines an oncolytic virus with a PD1 checkpoint inhibitor immunotherapy
http://immuno-oncologynews.com/2016/07/ ... notucirev/
http://www.psioxus.com/psioxus-technology.asp
http://www.businesswire.com/news/home/2 ... y-Clinical